Search results
A successful Alzheimer's drug will help Eli Lilly join the $1 trillion club
CNBC· 2 days agoEli Lilly became the most valuable health-care company in the world on the back of its blockbuster...
Alzheimer's drug with modest benefits wins backing of FDA advisers
Nature· 4 days agoDonanemab slows progression of symptoms, but questions linger about the durability of its effect.
Trouble for ecstasy? What MDMA’s FDA setback could mean for psychedelics
WLRN Miami· 15 hours agoThe psychedelic drug MDMA is near the end of decades-long effort to enter mainstream medicine but...
Galimedix Therapeutics Establishes Scientific Advisory Board of Renowned Retina Experts as Company...
Digital Journal· 3 days agoA SAB...clinical-stage private company developing novel oral and topical neuroprotective therapies with the potential to revolutionize the treatment of serious eye and brain
Opinion: Europe’s example on gender treatment
Deseret News via Yahoo News· 5 hours agoWhen it comes to transgender medical treatments for children, parts of Europe have taken an enviable approach that relies on science rather than...
Lifestyle Changes May Slow or Prevent Alzheimer’s in People at High Risk | FOX 28 Spokane
FOX 28 Spokane· 6 days agoNew research shows that a set of healthy lifestyle habits can help preserve brain function in folks...
5 things to know for June 11: Gaza ceasefire, Hunter Biden, Gun violence, Hurricane season,...
CNN via Yahoo News· 2 days agoThe drug works by helping the body remove amyloid plaque buildups in the brain that are a hallmark...
US proposal for cease-fire in Gaza gets UN Security Council backing | The Excerpt
USA TODAY via Yahoo News· 2 days agoAn FDA advisory panel has endorsed the experimental Alzheimer's drug donanemab. USA TODAY Education Reporter Alia Wong discusses chronic absenteeism and its consequences in ...
CAR-T cell therapy to treat blood cancers unlikely to increase risk of secondary cancers - UPI.com
UPI· 7 hours agoA study of more than 700 patients treated at Stanford University found that the risk of secondary...
ALZHEIMER'S DRUG DISCOVERY FOUNDATION'S (ADDF) STATEMENT ON FDA ADVISORY COMMITTEE'S ENDORSEMENT OF...
WKRN Nashville· 3 days agoIf approved, donanemab would become the second disease-modifying drug for Alzheimer's to receive full approval, expanding the arsenal of available drugs needed to treat Alzheimer's ...